NeOn project: UniSR in the research consortium led by Dompé
17 December 2020
Developing a platform dedicated to the research and development of new drugs for the treatment of degenerative diseases of the central nervous system, such as Alzheimer's, and oncology: this is the goal of the NeOn Project, which started after the agreement signed in Milan at the Dompé headquarters.
The biopharmaceutical company is the leader of a real "scientific consortium" that brings together organizations and companies among the highest levels of excellence in their respective areas of expertise. Among these, the Vita-Salute San Raffaele University, together with the University and Polytechnic of Milan, the European Institute of Oncology, the CNR Institute of Neuroscience, the Italian Institute of Technology, and the companies Proxentia srl and Neuro-zone srl.
“A virtuous example of how public and private come together to create excellence, for the local area and for patients”, said Sergio Dompé, President and CEO of Dompé Pharmaceuticals. "With 28 thousand employees in the sector, the Lombardy Region is the hub of the activity of centers of excellence recognized worldwide with which we will work to identify new therapeutic solutions".
The participation of the Vita-Salute San Raffaele University will involve numerous researchers who study the molecular mechanisms of neuronal degeneration in order to identify neuroprotective and neuroregenerative strategies.
"Our University, in addition to providing an essential scientific contribution, has had and continues to play a key role in coordinating, together with the lead partner Dompé, all management aspects ranging from project investigation to reporting activities"
states Dr. Daniele Zacchetti, project operational coordinator on behalf of the Vita-Salute San Raffaele University and senior researcher at the IRCCS San Raffaele Hospital.
The project therefore aims to be a virtuous example of public-private collaboration which, by pooling their respective skills, can generate an innovative research and development model that is significant in terms of scientific results that can be used and developed in the future by the same companies participating in the project or even from other future partners.